Ways2Capital Reviews : Cadila Healthcare Stock Drops 4%

Shares of Cadila Healthcare dropped 4% on the BSE. The company to raise funds by issue of Equity Shares/ convertible Bonds/ Debentures through Qualified Institutional Placement (QIPI/ GDR/ ADR, for an aggregate amount of up to Rs10,000cr, to issue Secured/ Unsecured redeemable non-convertible debentures/foreign currency bonds on private placement basis for an amount upto Rs3,500cr in the Financial year 2017-2018 and to issue Foreign Currency Bond/ Foreign Currency Convertible Bonds for an amount up to Rs5,000cr.

The company announced its numbers on May 25 after market hours. The company’s sales in Q4FY18 grew by 31.8% yoy to Rs3,250.2cr.

EBITDA grew by 87.4%yoy to Rs870.4cr in Q4FY18, EBITDA margins were at 26.8% in Q4FY18 vs. 26% in Q3FY18 and 18.8% in Q4FY17.

Adj PAT grew by 44.6% yoy to Rs595.5cr in Q4FY18.

The stock is currently trading at Rs367.45 down by Rs15.05 or 3.93% from its previous closing of Rs382.50 on the BSE.

The scrip opened at Rs388 and has touched a high and low of Rs389.55 and Rs361.55 respectively.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626191 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717
Share on Google Plus Share on Pinterest

About Bhoomi Desai